Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer

被引:77
作者
D'Amico, AV
Wu, YH
Chen, MH
Nash, M
Renshaw, AA
Richie, JP
机构
[1] Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Urol, Boston, MA 02115 USA
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
[5] Worcester Polytech Inst, Dept Math Sci, Worcester, MA 01609 USA
关键词
prostatic neoplasms; prostate-specific antigen; prostatectomy; outcome and process assessment (health care);
D O I
10.1097/00005392-200101000-00031
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The presence of perineural invasion on the prostate needle biopsy specimen has been suggested to be an independent predictor of prostate specific antigen (PSA) outcome following radical prostatectomy. We evaluated the clinical use of perineural invasion at biopsy for predicting time to PSA failure following radical prostatectomy after controlling for established prognostic factors. Materials and Methods: A prospective evaluation using a Cox regression multivariate analysis of 750 men with clinically localized or PSA detected prostate cancer was performed to evaluate the ability of PSA, biopsy Gleason score, perineural invasion on the needle biopsy specimen and the percent of positive prostate biopsies to predict PSA outcome following radical prostatectomy. Results: Multivariate analysis demonstrated that the presence of perineural invasion on the needle biopsy specimen provided additional information regarding 5-year PSA outcome (82% versus 95%, p = 0.04) for patients who were in the low risk group. This difference in PSA outcome could be explained by higher rates of positive surgical margins (25% versus 17%, p = 0.07). Patients whose prostate needle biopsy contained perineural invasion and who had the corresponding neurovascular bundle resected had a significantly lower positive margin rate (11% versus 100%, p = 0.001) compared to those who had the neurovascular bundle spared. The presence of perineural invasion on biopsy was not a significant predictor of PSA outcome following radical prostatectomy for patients in the intermediate or high risk group. Conclusions: Resection of the neurovascular bundle on the side corresponding to location of perineural invasion on the biopsy may decrease the positive surgical margin rate and improve outcome for low risk patients.
引用
收藏
页码:126 / 129
页数:4
相关论文
共 26 条
  • [1] [Anonymous], UROLOGIC PATHOLOGY
  • [2] TESTS FOR LINEAR TRENDS IN PROPORTIONS AND FREQUENCIES
    ARMITAGE, P
    [J]. BIOMETRICS, 1955, 11 (03) : 375 - 386
  • [3] RELATIONSHIP BETWEEN PERINEURAL TUMOR INVASION ON NEEDLE-BIOPSY AND RADICAL PROSTATECTOMY CAPSULAR PENETRATION IN CLINICAL STAGE-B ADENOCARCINOMA OF THE PROSTATE
    BASTACKY, SI
    WALSH, PC
    EPSTEIN, JI
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1993, 17 (04) : 336 - 341
  • [4] BEAHRS O, 1992, AJCC MANUAL STAGING
  • [5] Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
    D'Amico, AV
    Whittington, R
    Malkowicz, SB
    Schultz, D
    Blank, K
    Broderick, GA
    Tomaszewski, JE
    Renshaw, AA
    Kaplan, I
    Beard, CJ
    Wein, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (11): : 969 - 974
  • [6] Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer
    D'Amico, AV
    Whittington, R
    Malkowicz, SB
    Schultz, D
    Fondurulia, J
    Chen, MH
    Tomaszewski, JE
    Renshaw, AA
    Wein, A
    Richie, JP
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) : 1164 - 1172
  • [7] Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer
    D'Amico, AV
    Whittington, R
    Malkowicz, SB
    Fondurulia, J
    Chen, MH
    Kaplan, I
    Beard, CJ
    Tomaszewski, JE
    Renshaw, AA
    Wein, A
    Coleman, CN
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) : 168 - 172
  • [8] Prostate-specific antigen failure despite pathologically organ-confined and margin-negative prostate cancer: The basis for an adjuvant therapy trial
    DAmico, AV
    Whittington, R
    Malkowicz, SB
    Schultz, D
    Tomaszewski, JE
    Wein, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) : 1465 - 1469
  • [9] Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of >4-20 ng/ml
    DAmico, AV
    Whittington, R
    Kaplan, I
    Beard, C
    Jiroutek, M
    Malkowicz, SB
    Wein, A
    Coleman, CN
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (05): : 1053 - 1058
  • [10] Can perineural invasion on prostate needle biopsy predict prostate specific antigen recurrence after radical prostatectomy?
    de la Taille, A
    Rubin, MA
    Bagiella, E
    Olsson, CA
    Buttyan, R
    Burchardt, T
    Knight, C
    O'Toole, KM
    Katz, AE
    [J]. JOURNAL OF UROLOGY, 1999, 162 (01) : 103 - 106